Bladder Cancer Detection Kit Market Research Report - Global Forecast till 2027
Bladder Cancer Detection Kit Market
The bladder cancer detection kit
market is expected to cross ~USD 322.4 million by 2027 at a CAGR of ~11.17%.
The global bladder
cancer detection kit market is driven by several factors, such asthe increasing
prevalence of bladder cancer worldwide, surge in mortality rate due to bladder
cancer, rising demand for non-invasive detection of urothelial cancer, and
growing aging population. Moreover, the market players are developing products
and raising funds for marketing its product all across the world. The industry
players are focusing on the expansion of their distribution network and supply
chain to dominate the global bladder cancer detection kit market.
The key players are
involved in new product launches, strategic agreements, funding, investments,
and joint ventures to augment their market positions. For instance, in March
2021,OncoDiag (France) raised USD 3.0 million to commercialize its Urodiag
PCR-based diagnostic test for recurrent bladder cancer in order to expand its
international presencein Europe, the US, Canada, and Japan.Further, the
HirotsuBioScience (Japan)claimed that the clinical trials of their new early
detection kit found the test effective in 85% of cases using just a single drop
of urine. In addition, the doctors in Japan begun using the system from January
2020, with each test costing approximately USD 90. Hence, the emergence of such
products drives the market demand, fueling industry growth across the globe.
The launch of bladder cancertreatment procedures will increase customer
satisfaction and provide a wide variety of options for bladder cancer detection
kits.
Major Key
Players:
Some of the Bladder
Cancer Detection Kit Market Players are
Abbott Laboratories (US), Xiamen Biotime Biotechnology (China), Exact Sciences
(US), Hubei Jinjian Biology (China), Nanjing Liming Bio-products Co., Ltd.
(China), Abingdon Health (UK), Ameritek, Inc. (US), Alfa Scientific Designs
(US), NanoEnTek Inc. (South Korea), Diagnosis S.A. (Spain), and Xiamen Boson
Biotech Co., Ltd. (China).
Segment Analysis
The global bladder
cancer detection kit market has been segmented into technology and end user. By
technology, the market has been segregated into Fluorescence In Situ
Hybridization (FISH) Blood Sample Test Kit, Enzyme-Linked Immunosorbent Assay
(ELISA), and others. The FISHsegment is expected to hold a considerable share
of the market in 2020. The high demand for urine-based molecular test
products,such as Abbott’s UroVysion Bladder Cancer Kit approved by the FDA to
aid bladder cancer surveillance and assist with the diagnosis,will augment the
market growth in the assessed period.
Based on end user,
the global bladder cancer detection kit market has been classified as
hospitals& clinics, diagnostic centers, and others. The hospitals&
clinicssegment held the largest marketshare in 2020, owing to alarge number of
hospitals worldwide and the growing adoption of technologically advanced
products for the early detection of bladder cancer.
Regional Analysis
North America is expected to
dominate the bladder cancer detection kit market, owing to the high prevalence
of bladder cancer, adoption of technologically advanced products for bladder
cancer detection, and presence of major industry players across the region. In
addition, increased investments in R&D of the products by the government
and private organizations have surged the level of competition among the market
players. The prominent players are also involved in collaborations,
partnerships, and high investments in R&D activities which are contributing
to the market
growth.
Europeis expected to account for
the second-largest position in the bladder cancer detection kit market in 2021
due to the growing demand for the early detection and treatment of bladder
cancer across the region. In addition, countries such as Germany, the UK,
Sweden, France, and Switzerland have a large number of patients suffering from
bladder cancer. These countries have a rising adoption of technologically
advanced non-invasive detection kits. Hence, the aforementioned factors aid in
driving the market growth in the region.
Asia-Pacific is anticipated to be
the fastest-growing marketduring the forecast period dueto increasing
investment in healthcare infrastructure, rising number of geriatric population,
and growing awareness among the healthcare professionals about advanced bladder
cancer detection kits. In addition, the availability of qualified physicians
for consultation and treatment of bladder cancer is creating opportunities for
industry players.
Furthermore, the growth of the
market in the Rest of the World is attributed to the technological advancements
in bladder cancer detection kits coupled with the expansion of distribution
channels throughout the region.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment